Piramal Pharma Limited (NSE:PPLPHARMA)
India
· Delayed Price · Currency is INR 179.85
-1.00 (-0.55%)
At close: Dec 5, 2025
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 238.81 billion as of December 5, 2025. Its market cap has decreased by -28.45% in one year.
Market Cap
238.81B
Enterprise Value
279.88B
Revenue
89.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
179.85
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 238.81B, an increase of 5.33%. That is a compound annual growth rate of 1.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 238.81B | -32.34% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,331.52B |
| Divi's Laboratories | 1,718.51B |
| Cipla | 1,228.46B |
| Apollo Hospitals Enterprise | 1,033.74B |
| Zydus Lifesciences | 937.26B |
| Mankind Pharma | 910.34B |
| Aurobindo Pharma | 707.18B |
| Alkem Laboratories | 678.59B |